The development of drugs that specifically target fusion proteins encoded by these rearrangements [9, 11, 14] has driven
the need for systematic sensitive assays to detect them. Lung cancer fusions have traditionally been detected using FISH, IHC, or RT-PCR. While FISH is[r]